Journal of Cardiovascular Pharmacology and Therapeutics

SAGE Publishing

Journal websitePeer review: Other
Evaluation status available after sign-in
Follow this journal
PrintDownload PDF

About the journal

Journal of Cardiovascular Pharmacology and Therapeutics is an open-access journal published by SAGE Publishing in United States, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 1,325 USD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
1074-2484 · 1940-4034
Country
United States
Languages
english
Access
Open access
Declared publication charge
1,325 USD
Articles in DOAJ
120
Declared review time
12 weeks
Declared peer-review model
other
Official website
https://journals.sagepub.com/home/cpt

Index listings

  • DOAJ · 2022-03-03
  • MEDLINE · 2000-01-01
Indexing
DOAJ · MEDLINE
APC
1,325 USD
Declared review time (DOAJ)
12 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

120

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

12weeks

Works in OpenAlex

1417

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

68

i10-index

839

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2024-04-04
Added to DOAJ
2022-03-03
Declared plagiarism screening
Declared
Other fees beyond APC
No
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
93%
ORCID iDs in current deposits
92%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Journal of cardiovascular pharmacology & therapeuticsJCPT
Source type
journal
NLM unique ID (PubMed)
9602617
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) systemMedicine: Therapeutics. Pharmacology

LCC codes

RC666-701RM1-950

Subject areas

  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Ischemia and Reperfusion
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Ischemia and Reperfusion
  • Cardiac Ischemia and Reperfusion
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
Show all subjects (75)
  • Cardiac Fibrosis and Remodeling
  • Atrial Fibrillation Management and Outcomes
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Heart Failure Treatment and Management
  • Cardiac Arrhythmias and Treatments
  • Heart Failure Treatment and Management
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Heart Failure Treatment and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Blood Pressure and Hypertension Studies
  • Cardiac Arrhythmias and Treatments
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Function and Risk Factors
  • Nitric Oxide and Endothelin Effects
  • Coronary Interventions and Diagnostics
  • Renin-Angiotensin System Studies
  • Acute Myocardial Infarction Research
  • Acute Myocardial Infarction Research
  • Cardiac Arrest and Resuscitation
  • Cardiac Arrest and Resuscitation
  • Cholesterol and Lipid Metabolism
  • Ion channel regulation and function
  • Ion channel regulation and function
  • Cardiovascular Function and Risk Factors
  • Nitric Oxide and Endothelin Effects
  • Blood Pressure and Hypertension Studies
  • Nitric Oxide and Endothelin Effects
  • Blood Pressure and Hypertension Studies
  • Venous Thromboembolism Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Fibrosis and Remodeling
  • Cardiac Fibrosis and Remodeling
  • Cardiac pacing and defibrillation studies
  • Blood Coagulation and Thrombosis Mechanisms
  • Cardiac pacing and defibrillation studies
  • Cardiac pacing and defibrillation studies
  • Venous Thromboembolism Diagnosis and Management
  • Heart rate and cardiovascular health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Atherosclerosis and Cardiovascular Diseases
  • Ion channel regulation and function
  • Cardiac Imaging and Diagnostics
  • Renin-Angiotensin System Studies
  • Coronary Interventions and Diagnostics
  • Coronary Interventions and Diagnostics
  • Renin-Angiotensin System Studies
  • Cardiac and Coronary Surgery Techniques
  • Cardiac Imaging and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Anesthesia and Neurotoxicity Research
  • Anesthesia and Neurotoxicity Research
  • Cardiovascular Health and Disease Prevention
  • Heart Rate Variability and Autonomic Control
  • Heart Rate Variability and Autonomic Control
  • Cardiac Arrest and Resuscitation
  • Heart rate and cardiovascular health
  • Heart rate and cardiovascular health
  • Cancer, Lipids, and Metabolism
  • Hormonal Regulation and Hypertension
  • Hormonal Regulation and Hypertension
  • Cancer, Lipids, and Metabolism

Keywords (DOAJ)

  • therapeutic approaches
  • cardiovascular diseases
  • congestive heart failure
  • hypertension
  • hypotension
  • preventive cardiology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: